Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

When Food Is Engineered to Be Addictive

The Milbank Quarterly finds makers used tobacco-like tactics — pairing refined carbs and fats with sensory design — to overwhelm satiety and spur compulsive eating.

How to Recognize Obsessive-Compulsive Disorder in Children

Dr Aron explains that screening tools and insight into the disorder can speed diagnosis of OCD.

The Rise of Zip-Code Immunity

With the CDC compromised by vaccine skeptics, states are being forced to build their own public health infrastructure.

When NPs and PAs Manage Cases Outside Their Specialty

Curbside consultations may take many forms, and there are significant benefits and risks involved.

NP Integration Boosts Osteoporosis Documentation

The integration of a nurse practitioner into the orthopedic inpatient workflow improves osteoporosis documentation substantially after hip fractures.

Researchers, Advocates Welcome EO on Psychedelics

The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially stepped-up rescheduling of the drugs.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

The Milbank Quarterly finds makers used tobacco-like tactics — pairing refined carbs and fats with sensory design — to overwhelm satiety and spur compulsive eating.

Dr Aron explains that screening tools and insight into the disorder can speed diagnosis of OCD.

With the CDC compromised by vaccine skeptics, states are being forced to build their own public health infrastructure.

Curbside consultations may take many forms, and there are significant benefits and risks involved.

The integration of a nurse practitioner into the orthopedic inpatient workflow improves osteoporosis documentation substantially after hip fractures.

The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially stepped-up rescheduling of the drugs.

News All Time

Suspected LGA Diagnosis May Drive Obstetric Decisions

In a study of pregnant patients, suspected large for gestational age is associated with shifts in labor management, regardless of actual fetal size.

How Male Anatomy Became Medicine’s Default and What It Means

Medical education continues to rely on male anatomy as the standard, raising concerns about diagnostic accuracy and treatment outcomes in women.

Early Emotions Shape Long-Term Mental Health in JIA

An individual's emotional state at the time of juvenile idiopathic arthritis diagnosis is linked to their future mental health outcomes.

What Precedes Aid With Dying in Young Adults With Cancer?

Researchers analyze experiences and characteristics of a cohort of adolescent and young adult patients with cancer who received medical assistance in dying in Canada.

Non-Medicinal Satiety Tips PCPs Can Suggest for Weight Loss

An emphasis on fiber and protein in food can help patients find success.

Shockwave Therapy for Erectile Dysfunction: Does It Work?

Low-intensity shockwave therapy improves erectile function in trials, but guidelines continue to classify it as investigational pending stronger long-term evidence.

Inpatient Obesity Interventions Offer Opportunities

Hospitalization may provide a wake-up call and a chance for focused interventions.

Women With SLE Show Higher Rates of Cervical HPV Infection

Women with systemic lupus erythematosus who receive immunosuppressive therapy show a higher prevalence of cervical lesions and cervical human papillomavirus infection than immunocompetent women.

Aerobic Exercise Tied to Improved Mobility, Alertness in PD

Aerobic exercise may help ease depression and daytime sleepiness in Parkinson’s disease, though its benefits for mobility, cognition, and sleep appear limited.

Episode 2: Diagnosing and Managing Cushing Syndrome

Drs Marwah Abdalla and Lewis Blevins discuss Cushing syndrome: Why it is frequently missed, how clinicians can screen for it, and how to manage it.

MASLD for Cardiologists

An overview of MASLD, including the epidemiology, diagnostic approaches, and therapeutic options highlighting the cardiologists’ role in its multidisciplinary management.

Jan 30 2026 This Week in Cardiology

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Mandrola, MD, in this week’s podcast.

Exogenous Ketones and Exercise Tolerance: KETO-HFpEF

A crossover trial to determine whether ketone ester improves exercise tolerance in HFpEF.

Frailty in CVD: Time for a Universal Definition!

Citing The Death of Ivan Ilyich, the authors call for professional societies to jointly embrace a core definition of frailty for cardiovascular care and clinical practice.

Feb 06 2026 This Week in Cardiology

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Mandrola, MD, discusses in this week’s podcast.

Nut Consumption Linked to Improved Sperm Quality

A Spanish cross-sectional study of 222 men finds that those with the highest nut intake have higher sperm counts and 75% lower odds of abnormal motility, especially among men adhering to a Mediterranean diet.

Recommended News For You

EVP Beats Cisplatin for Resectable MIBC

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

Recommended Articles For You

Exploring the Latest Treatments for Desmoid Tumors 

The Truth About Marijuana and Its Effect on Mental Health  

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines 

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How AI will transform mental health support for patients with breast cancer

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

4.

Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition

5.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

1.

Tazemetostat: A Promising New Treatment for Cancer

2.

Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection

3.

Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results

4.

Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options 

5.

The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot